Home › Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results
 

Keywords :   


Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results

2014-11-18 11:35:59| Semiconductors - Topix.net

Bio-Path Holdings, Inc., , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. The final patient of cohort six completed treatment in the Phase I clinical trial evaluating Bio-Path's lead product candidate, BP-100-1.01 in blood cancers.

Tags: results reports financial quarter

Category:Electronics and Electrical

Latest from this category

All news
»
06.07Tropical Storm Beryl Forecast Discussion Number 30
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Tropical Storm Beryl Forecast Advisory Number 30
06.07Post-Tropical Cyclone Aletta Graphics
06.07Post-Tropical Cyclone Aletta Wind Speed Probabilities Number 7
06.07Post-Tropical Cyclone Aletta Forecast Advisory Number 7
06.07Post-Tropical Cyclone Aletta Public Advisory Number 7
06.07Summary for Post-Tropical Cyclone Aletta (EP1/EP012024)
More »